OOIR: Observatory of International Research

Papers

(The H4-Index of Transfusion and Apheresis Science is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study	140
Treatment for emerging viruses: Convalescent plasma and COVID-19	109
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection	63
Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia	61
Inventory management in blood supply chain considering fuzzy supply/demand uncertainties and lateral transshipment	49
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma	46
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia	38
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia	35
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario	34
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis	33
COVID-19 and the ABO blood group connection	33
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine	33
Patient blood management: The best approach to transfusion medicine risk management	32
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy	31
CRISPR/Cas9 gene editing for curing sickle cell disease	30
Convalescent plasma therapy in patients with COVID-19	30
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma	30
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike	29
Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection	26
Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?	25
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma	25
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries	24
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation	24